CURE TV®

With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

Family of First Patient with Pediatric Cancer to Receive CAR-T Cell Therapy Opens Up About Treatment

October 8th 2020

Emily Whitehead’s family details her journey with cancer and how advocating for their daughter led to Emily’s extraordinary CAR-T cell therapy treatment.

‘We Need to Do Better’ for Patients with Cancer Suffering from Treatment-Related Dry Mouth

October 8th 2020

Outside of drinking plenty of water or avoiding foods that can induce dry mouth, Dr. Randy Kimple notes that there are very few effective treatments for patients who experience cancer treatment-related dry mouth.

‘You Never Know When Things Could Change in an Instant’ Says Pediatric Cancer Survivor

October 7th 2020

In an interview with CURE®, Emily Whitehead details her journey as a pediatric cancer survivor and how you won’t be able to predict it.

Treatment for Radiation-Related Dry Mouth Could Offer Benefits to Those Outside the Cancer Space

October 7th 2020

Potentially curative therapies for radiation-related dry mouth aren’t only beneficial for patients with cancer, but others who suffer from dry mouth in general.

Lung Cancer Survivor Offers Advice to the Newly Diagnosed

October 6th 2020

Cancer survivor offers his advice to the newly diagnosed as they start their treatment journey.

Experimental Regenerative Medicine Therapy Could Benefit Patients with Cancer Treatment-Related Dry Mouth

October 6th 2020

Dry mouth is a common cancer treatment-related side effect for patients, but a new experimental therapy could help with that.

Dealing with the Isolation of Cancer Treatment

October 5th 2020

Larry Whipple had to travel 1,500 miles from his hometown for a second opinion after he was diagnosed with advanced lung cancer, but through the course of his treatment he had to remain in isolation to avoid further illness.

What the FDA’s New Breast Implant Recommendations Mean for Patients

September 30th 2020

In an interview with CURE®, the president of the National Center for Health Research elaborates on the effort to protect patients from potentially serious side effects associated with getting breast implants, including breast implant-associated anaplastic large cell lymphoma.

The Problem with the Cancer ‘Battle’

September 18th 2020

The terminology surrounding the cancer journey is often associated with a “battle” and can misconstrue the experience of treatment.

Overuse of Antibiotics Could Be Linked to Rise in Early-Onset Colorectal Cancer, Says One Expert

September 18th 2020

Dr. Mark Lewis discusses the rise of early-onset colorectal cancer, as awareness for the disease has spiked in the wake of Chadwick Boseman’s passing, being linked to the overuse of antibiotics.

How Younger Patients With Colorectal Cancer Symptoms Can Be Better Self Advocates

September 15th 2020

Young-onset colorectal cancer is sometimes hard for patients to talk about due to stigma, but one oncologist discusses how patients can be better self-advocates.

An Expert Explains the Three Major Treatment Modalities in Triple Negative Breast Cancer

September 15th 2020

“In the field of triple-negative breast cancer, we're beginning to see some remarkable advances, mostly centering around the three paradigms that have become so attractive for the treatment of cancer: immunotherapy, targeted biologics and antibody-drug conjugates,” Dr. Howard A. “Skip” Burris, III said in an interview.

When it Comes to Cancer, 'You Never Know What Someone is Going Through'

September 15th 2020

The death of actor Chadwick Boseman from colorectal cancer has brought to light that many people with cancer fight their battles quietly, and how even oncologists need to be considerate of a patient’s struggles despite how they appear.

What Certain Patients with DLBCL Need To Know About Monjuvi-Revlimid

September 14th 2020

Patients with relapsed/refractory diffuse large B-cell lymphoma who are unable to undergo autologous stem cell transplant have a new treatment option in the combination of Monjuvi and Revlimid. The lead researcher on the study that led to the combination’s approval discusses what patients need to know.

Chadwick Boseman’s Death Highlights Need for Earlier Screening in Colorectal Cancer

September 14th 2020

The recent death of Chadwick Boseman highlights the need for earlier screening in colorectal cancer, especially for young people.

Cirmtuzumab Combinations Show Potential in Treatment of Mantle Cell Lymphoma

September 9th 2020

Dr. Lori A. Leslie discuses the potential of combination therapies with the emerging agent cirmtuzumab for patients with mantle cell lymphoma.

Personalized Medicine, Genetic Testing Could Shape the Future of Non-Small Cell Lung Cancer

September 9th 2020

Dr. Nathan A. Pennell discusses the key genetic markers for treating patients with non-small cell lung cancer with targeted therapies.

Age and Gender Could Factor into Advanced Renal Cell Carcinoma Outcomes

September 1st 2020

Many factors impact outcomes in patients with advanced renal cell carcinoma, but recent findings suggest a patient’s age and gender are perhaps more important than previously realized.

More Effective Treatment Options are Needed for Patients with Advanced Multiple Myeloma

August 20th 2020

Despite recent advances in the treatment of multiple myeloma, more must be done to find effective treatment options for patients with advanced disease, according to Dr. Luciano J. Costa.

Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma

August 18th 2020

While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field forward.

An Expert Discusses the Future of Multiple Myeloma Treatments

August 18th 2020

The future of multiple myeloma is heading toward combination therapies and CAR-T cell treatments, according to Dr. Betsy O'Donnell.

More Quality-of-Life Research ‘Extremely Important’ for Patients with Cancer

August 17th 2020

“Therapeutic trials are very, very important because thanks to them, our patients are living longer,” said Dr. Narjust Duma. “But (physicians) also need to stop and ask how our patients are living.”

COVID-19 Puts Supportive Care Studies on Hold for Patients With Lung Cancer

August 15th 2020

Dr. Richard J. Gralla discusses some of the studies in supportive care that have been put on hold due to the ongoing COVID-19 pandemic.

Pioneer in Supportive Care Research Discusses History of Emesis Management

August 14th 2020

Dr. Ricahrd J Gralla discusses the history of the early medical oncology space and how things have changed when it comes to treating side effects related to chemotherapy.

How Patients Can Mitigate the Heart-Related Side Effects of Prostate Cancer Treatment

August 14th 2020

Prostate cancer treatments can cause side effects in a part of the body that might be unexpected— the heart. Here's how one expert believes patients can mitigate them. 

How Governor Larry Hogan Leaned on Family After a Cancer Diagnosis

August 13th 2020

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

Investigating the Role of Video Genetic Counseling in Prostate Cancer

August 11th 2020

Genetic testing is proving itself to be a vital tool in treating patients with prostate cancer but educating men on its importance also needs to take priority.

Options for Patients with Mantle Cell Lymphoma Are 'Exploding', Expert Says

August 10th 2020

“It really is an exciting time for patients with lymphoma, because the options are just really exploding at a very encouraging rate,” said Dr. Lori A. Leslie.

An Expert Looks to the Future of Metastatic Kidney Cancer Treatment

August 10th 2020

Dr. Toni K. Choueiri discusses what therapies are currently available for patients with metastatic renal cell carcinoma, as well as what new treatments could be on the horizon.

Minimal Residual Disease is A Vital Marker for Patients with Multiple Myeloma, Says Expert

July 31st 2020

Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.